BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26566019)

  • 21. Reduced Chronic Lymphocyte Activation following Interferon Alpha Blockade during the Acute Phase of Simian Immunodeficiency Virus Infection in Rhesus Macaques.
    Carnathan D; Lawson B; Yu J; Patel K; Billingsley JM; Tharp GK; Delmas OM; Dawoud R; Wilkinson P; Nicolette C; Cameron MJ; Sekaly RP; Bosinger SE; Silvestri G; Vanderford TH
    J Virol; 2018 May; 92(9):. PubMed ID: 29467313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation.
    Anderson AC; Joller N; Kuchroo VK
    Immunity; 2016 May; 44(5):989-1004. PubMed ID: 27192565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy.
    Asano T; Meguri Y; Yoshioka T; Kishi Y; Iwamoto M; Nakamura M; Sando Y; Yagita H; Koreth J; Kim HT; Alyea EP; Armand P; Cutler CS; Ho VT; Antin JH; Soiffer RJ; Maeda Y; Tanimoto M; Ritz J; Matsuoka KI
    Blood; 2017 Apr; 129(15):2186-2197. PubMed ID: 28151427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined Env- and Gag-specific T cell responses in relation to programmed death-1 receptor and CD4 T cell loss rates in human immunodeficiency virus-1 infection.
    Pettersen FO; Taskén K; Kvale D
    Clin Exp Immunol; 2010 Aug; 161(2):315-23. PubMed ID: 20491784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune Co-inhibitory Receptors PD-1, CTLA-4, TIM-3, LAG-3, and TIGIT in Medullary Thyroid Cancers: A Large Cohort Study.
    Shi X; Li CW; Tan LC; Wen SS; Liao T; Zhang Y; Chen TZ; Ma B; Yu PC; Lu ZW; Qu N; Wang Y; Shi RL; Wang YL; Ji QH; Wei WJ
    J Clin Endocrinol Metab; 2021 Jan; 106(1):120-132. PubMed ID: 33000173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS.
    Nilsson J; Boasso A; Velilla PA; Zhang R; Vaccari M; Franchini G; Shearer GM; Andersson J; Chougnet C
    Blood; 2006 Dec; 108(12):3808-17. PubMed ID: 16902147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Second- and third-generation drugs for immuno-oncology treatment-The more the better?
    Dempke WCM; Fenchel K; Uciechowski P; Dale SP
    Eur J Cancer; 2017 Mar; 74():55-72. PubMed ID: 28335888
    [TBL] [Abstract][Full Text] [Related]  

  • 28. On the role of the inhibitory receptor LAG-3 in acute and chronic LCMV infection.
    Richter K; Agnellini P; Oxenius A
    Int Immunol; 2010 Jan; 22(1):13-23. PubMed ID: 19880580
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression.
    Vali B; Jones RB; Sakhdari A; Sheth PM; Clayton K; Yue FY; Gyenes G; Wong D; Klein MB; Saeed S; Benko E; Kovacs C; Kaul R; Ostrowski MA
    Eur J Immunol; 2010 Sep; 40(9):2493-505. PubMed ID: 20623550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory Receptors.
    Thommen DS; Schreiner J; Müller P; Herzig P; Roller A; Belousov A; Umana P; Pisa P; Klein C; Bacac M; Fischer OS; Moersig W; Savic Prince S; Levitsky V; Karanikas V; Lardinois D; Zippelius A
    Cancer Immunol Res; 2015 Dec; 3(12):1344-55. PubMed ID: 26253731
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Programmed Cell Death 1 (PD-1) and Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) in Viral Hepatitis.
    Cho H; Kang H; Lee HH; Kim CW
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28703774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-mediated phosphatidylinositol 3-kinase/serine-threonine kinase activation in APCs leads to programmed death-1 ligand upregulation and suppression of HIV-specific CD8 T cells.
    Muthumani K; Shedlock DJ; Choo DK; Fagone P; Kawalekar OU; Goodman J; Bian CB; Ramanathan AA; Atman P; Tebas P; Chattergoon MA; Choo AY; Weiner DB
    J Immunol; 2011 Sep; 187(6):2932-43. PubMed ID: 21856939
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination Immune Checkpoint Blockade to Reverse HIV Latency.
    Van der Sluis RM; Kumar NA; Pascoe RD; Zerbato JM; Evans VA; Dantanarayana AI; Anderson JL; Sékaly RP; Fromentin R; Chomont N; Cameron PU; Lewin SR
    J Immunol; 2020 Mar; 204(5):1242-1254. PubMed ID: 31988180
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CTLA-4 blockade decreases TGF-beta, IDO, and viral RNA expression in tissues of SIVmac251-infected macaques.
    Hryniewicz A; Boasso A; Edghill-Smith Y; Vaccari M; Fuchs D; Venzon D; Nacsa J; Betts MR; Tsai WP; Heraud JM; Beer B; Blanset D; Chougnet C; Lowy I; Shearer GM; Franchini G
    Blood; 2006 Dec; 108(12):3834-42. PubMed ID: 16896154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD4+ T Cells Expressing PD-1, TIGIT and LAG-3 Contribute to HIV Persistence during ART.
    Fromentin R; Bakeman W; Lawani MB; Khoury G; Hartogensis W; DaFonseca S; Killian M; Epling L; Hoh R; Sinclair E; Hecht FM; Bacchetti P; Deeks SG; Lewin SR; Sékaly RP; Chomont N
    PLoS Pathog; 2016 Jul; 12(7):e1005761. PubMed ID: 27415008
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immune inhibitory proteins and their pathogenic and therapeutic implications in autoimmunity and autoimmune hepatitis.
    Czaja AJ
    Autoimmunity; 2019 Jun; 52(4):144-160. PubMed ID: 31298041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Checkpoint inhibitors in hematological malignancies.
    Ok CY; Young KH
    J Hematol Oncol; 2017 May; 10(1):103. PubMed ID: 28482851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Feline immunodeficiency virus infection phenotypically and functionally activates immunosuppressive CD4+CD25+ T regulatory cells.
    Vahlenkamp TW; Tompkins MB; Tompkins WA
    J Immunol; 2004 Apr; 172(8):4752-61. PubMed ID: 15067051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression Analysis and Significance of PD-1, LAG-3, and TIM-3 in Human Non-Small Cell Lung Cancer Using Spatially Resolved and Multiparametric Single-Cell Analysis.
    Datar I; Sanmamed MF; Wang J; Henick BS; Choi J; Badri T; Dong W; Mani N; Toki M; Mejías LD; Lozano MD; Perez-Gracia JL; Velcheti V; Hellmann MD; Gainor JF; McEachern K; Jenkins D; Syrigos K; Politi K; Gettinger S; Rimm DL; Herbst RS; Melero I; Chen L; Schalper KA
    Clin Cancer Res; 2019 Aug; 25(15):4663-4673. PubMed ID: 31053602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expansion of dysfunctional Tim-3-expressing effector memory CD8+ T cells during simian immunodeficiency virus infection in rhesus macaques.
    Fujita T; Burwitz BJ; Chew GM; Reed JS; Pathak R; Seger E; Clayton KL; Rini JM; Ostrowski MA; Ishii N; Kuroda MJ; Hansen SG; Sacha JB; Ndhlovu LC
    J Immunol; 2014 Dec; 193(11):5576-83. PubMed ID: 25348621
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.